<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/157</identifier>
				<datestamp>2024-10-30T18:55:45Z</datestamp>
				<setSpec>aavptbiennial:S1</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">The Regulation of Veterinary Pharmaceuticals and Biologicals: Quo Vadis?</dc:title>
	<dc:creator xml:lang="en">Crawford, Lester M.</dc:creator>
	<dc:subject xml:lang="en">drug regulation</dc:subject>
	<dc:subject xml:lang="en">drug use</dc:subject>
	<dc:subject xml:lang="en">food animals</dc:subject>
	<dc:subject xml:lang="en">horses</dc:subject>
	<dc:subject xml:lang="en">dogs</dc:subject>
	<dc:subject xml:lang="en">bioengineered products</dc:subject>
	<dc:subject xml:lang="en">decision-making</dc:subject>
	<dc:description xml:lang="en">Current efforts on the part of USDA to modernize the Virus-Serum-Toxin Act are therefore laudable. I support those efforts. There are of course disparate points of view. The Congressional Office of Technology Assessment has reviewed the issue and has concluded that regulation of all veterinary products, including immunizing agents, should repose in FDA. I predict an eventual resolution here, but not until all sides of the issue have been aired through the law-making process.
Quo vadis, Center for Veterinary Medicine? Let's look at the major issues CVM will be dealing with between 1984-90. I think these will include: 1) illegal drug use in food animals; 2) use of drugs in racing horses and dogs; 3) the approval of bioengineered products; 4) minor species drugs; 5) the conversion from process-oriented decision-making to scientific-oriented decision-making.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1984-04-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/157</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fourth Symposium; 7-12</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/157/150</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1984 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
